{"entity":{"type":"insider","cik":"0001643875","url":"/insider/0001643875","json_url":"/insider/0001643875.json","name":"Braunstein Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":7,"first":"2016-02-01","last":"2025-02-11","span_basis":"filed_date"},"name_variants":[{"name":"Braunstein Scott","source":"filing","n_filings":7,"first_seen":"2016-02-01","last_seen":"2025-02-11"}],"transactions":[{"id":4509535,"accession":"0001104659-25-011239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-011239","line_url":"/filing/0001104659-25-011239#line-1","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS, INC.","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Director, Officer (CHAIRMAN AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN AND CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5933.0,"shares_display":"5,933","price_per_share":1.1,"price_display":"1.10","price_state":"stated","total_value":6526.3,"total_display":"6,526.30","total_whole":"6,526","shares_owned_after":304600.0,"shares_owned_after_display":"304,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2025-02-11","scope":"insider"},{"id":2370647,"accession":"0001415889-24-020894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-020894","line_url":"/filing/0001415889-24-020894#line-1","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS, INC.","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Director, Officer (CHAIRMAN AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12145.0,"shares_display":"12,145","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":13723.85,"total_display":"13,723.85","total_whole":"13,724","shares_owned_after":298667.0,"shares_owned_after_display":"298,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-05","filed_date":"2024-08-07","scope":"insider"},{"id":2928009,"accession":"0001415889-24-004575","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-004575","line_url":"/filing/0001415889-24-004575#line-1","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS, INC.","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Director, Officer (CHAIRMAN AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11850.0,"shares_display":"11,850","price_per_share":9.94,"price_display":"9.94","price_state":"stated","total_value":117789.0,"total_display":"117,789.00","total_whole":"117,789","shares_owned_after":223512.0,"shares_owned_after_display":"223,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-21","scope":"insider"},{"id":7901556,"accession":"0001415889-23-011951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-011951","line_url":"/filing/0001415889-23-011951#line-2","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS, INC.","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Director, Officer (CHAIRMAN AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30.0,"shares_display":"30","price_per_share":8.94,"price_display":"8.94","price_state":"stated","total_value":268.2,"total_display":"268.20","total_whole":"268","shares_owned_after":160762.0,"shares_owned_after_display":"160,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-08","scope":"insider"},{"id":7901554,"accession":"0001415889-23-011951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-23-011951","line_url":"/filing/0001415889-23-011951#line-1","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS, INC.","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Director, Officer (CHAIRMAN AND CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHAIRMAN AND CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6413.0,"shares_display":"6,413","price_per_share":9.55,"price_display":"9.55","price_state":"stated","total_value":61244.15,"total_display":"61,244.15","total_whole":"61,244","shares_owned_after":160792.0,"shares_owned_after_display":"160,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-08","scope":"insider"},{"id":7834005,"accession":"0001104659-19-072572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-072572","line_url":"/filing/0001104659-19-072572#line-1","is_derivative":false,"issuer_cik":"0001267813","issuer_name":"MARINUS PHARMACEUTICALS INC","issuer_ticker":"MRNS","issuer_name_source":null,"issuer_url":"/issuer/0001267813","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.25,"price_display":"1.25","price_state":"stated","total_value":125000.0,"total_display":"125,000.00","total_whole":"125,000","shares_owned_after":100000.0,"shares_owned_after_display":"100,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-13","scope":"insider"},{"id":5351814,"accession":"0001209191-17-038416","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-038416","line_url":"/filing/0001209191-17-038416#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Officer (SVP, Strategy & Corp. Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Strategy & Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Strategy & Corp. Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":768.0,"shares_display":"768","price_per_share":43.321,"price_display":"43.32","price_state":"stated","total_value":33270.528,"total_display":"33,270.53","total_whole":"33,271","shares_owned_after":9982.0,"shares_owned_after_display":"9,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-07","scope":"insider"},{"id":3166983,"accession":"0001209191-16-094564","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-094564","line_url":"/filing/0001209191-16-094564#line-1","is_derivative":false,"issuer_cik":"0001396814","issuer_name":"Pacira Pharmaceuticals, Inc.","issuer_ticker":"PCRX","issuer_name_source":null,"issuer_url":"/issuer/0001396814","owner_cik":"0001643875","owner_name":"Braunstein Scott","owner_display_name":"Braunstein Scott","owner_url":"/insider/0001643875","role":"Officer (SVP, Strategy & Corp. Dev)","role_mark":"O","role_mark_label":"Officer (SVP, Strategy & Corp. Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Strategy & Corp. Dev.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":58.92,"price_display":"58.92","price_state":"stated","total_value":117840.0,"total_display":"117,840.00","total_whole":"117,840","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-29","filed_date":"2016-02-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001267813","name":"MARINUS PHARMACEUTICALS, INC.","url":"/issuer/0001267813","role":"Director, Officer (CHAIRMAN AND CEO)","n_filings":5,"first_seen":"2019-12-13","last_seen":"2025-02-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001396814","name":"Pacira Pharmaceuticals, Inc.","url":"/issuer/0001396814","role":"Officer (SVP, Strategy & Corp. Dev)","n_filings":2,"first_seen":"2016-02-01","last_seen":"2017-06-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001643875","retrieved_at":"2026-08-23T15:53:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}